OncoSec CFO George Chi terminated for cause effective June 12, 2023

ONCOSEC MEDICAL Inc

George Chi terminated for cause as CFO; termination not related to financial results or reporting disagreements.
Effective June 12, 2023; no replacement named in the filing.
Chi not entitled to severance; will receive salary and benefits earned through June 12, 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

George Chi

Chief Financial Officer

ONCOSEC MEDICAL Inc

Effective: 2023-06-12
Filed: June 14, 2023, 7:59 PM ET

On June 12, 2023, George Chi was terminated for cause as an employee and Chief Financial Officer of OncoSec Medical Incorporated (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

George Chi was terminated as Chief Financial Officer at ONCOSEC MEDICAL Inc.

Action: terminated
Role: Chief Financial Officer

Exact text from the filing

On June 12, 2023, George Chi was terminated for cause as an employee and Chief Financial Officer of OncoSec Medical Incorporated (the “Company”), effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-23-021260

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.